The relationship between airways inflammation and asthma severity

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 1, 2000, Pages 9-16

  Louis, Renaud ^a,b,c,d   Lau, Laurie C K ^a,b,c   Bron, Adriaan O ^a,b,c   Roldaan, Albert C ^a,b,c   Radermecker, Maurice ^a,b,c   Djukanović, Ratko ^a,b,c,e  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Dutch Asthma Centre   (Switzerland)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UCB Institute of Allergy   (Belgium)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE;

ADULT; AIRWAY; ARTICLE; ASTHMA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0033954741     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.1.9802048     Document Type: Article

References (40)

1. 1. NHLBI/WHO Workshop Report. 1995. Global strategy for asthma management and prevention. National Institutes of Health. National Heart, Lung, and Blood Institute, Bethesda, MD. Publication No. 95-3659.
2. 2. Kamada, A. K., S. J. Szefler, R. J. Martin, H. A. Boushey, V. M. Chinchilli, J. M. Drazen, J. E. Fish, E. Israel, S. C. Lazarus, and R. F. Lemanske. 1996. Issues in the use of inhaled glucocorticoids. Am. J. Respir. Crit. Care Med. 153:1739-1748.
3. 3. Fahy, J., J. Liu, H. Wong, and H. Boushey. 1993. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am. Rev. Respir. Dis. 147:1126-1131.
4. 4. Pizzichini, E., M. M. M. Pizzichini, A. Efthimiades, S. Evans, M. M. Morris, D. Squillace, G. J, Gleich, J. Dolovich, and F. E. Hargreave. 1996. Indices of airway inflammation in induced sputum: reproducibility and viability of cell and fluid-phase measurements. Am. J. Respir. Crit. Care Med. 154:308-317.
5. 5. Djukanović, R., J. W. Wilson, K. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. Effect of inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 145:669-674.
6. 6. Louis, R., J. Shute, S. Biagi, L. Stanciu, F. Marelli, H. Tenor, R. Hidi, and R. Djukanović. 1997. Cell infiltration ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum. Am. J. Respir. Crit. Care Med. 155:466-472.
7. 7. He, S., and A. F., Walls. 1997. Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation. Eur. J. Pharmacol. 328: 89-97.
8. 8. Jung, K., J. Shute, J. Cairns, M. K. Church, and A. F. Walls. 1995. Human mast cell tryptase: a mediator of eosinophil chemotaxis and degranulation (abstract). Am. J. Respir. Crit. Care Med. 151:A530.
9. 9. Kraft, M., G. H. Cassell, M. Aemi, L. B. Duffy, G. Georges, J. Pak, and R. J. Martin. 1997. Mycoplasma pneumoniae as a cofactor in the pathogenesis of chronic asthma (abstract). Eur. Respir. J. 10(Suppl.):A27.
10. 10. Bousquet, J., P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
11. 11. Wardlaw, A. J., S. Dunnette, G. J. Gleich, J. V. Collins, and A. B. Kay. 1988. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:62-69.
12. 12. Fergusson, A., and F. Wong. 1989. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in bronchoalveolar lavage fluid. Chest 96:988-991.
13. 13. Walker, C., M. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:935-942.
14. 14. Bradley, B. L., M. Azzawi, M. Jacobson, B. Assouffi, J. V. Collins, A. Irani, L. Schwartz, S. R. Durham, P. K. Jeffery, and A. B. Kay. 1991. Eosinophils, T lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J. Allergy Clin. Immunol. 88:661-674.
15. 15. Claman, D., H. Boushey, J. Liu, H. Wong, and J. Fahy. 1994. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 94:861-869.
16. 16. Sont, J. K., J. Han, J. van Kieken, C. Evertse, R. Hooijer, L. Willems, and P. J. Sterk. 1996. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 51:496-502.
17. 17. Iredale, M., S. Wanklyn, I. Phillips, T. Krauz, and P. Ind. 1994. Noninvasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness of inhaled hypertonic saline. Clin. Exp. Allergy 24:940-945.
18. 18. Crimi, E., A. Spanavello, M. Neri, P. Ind, G. Rossi, and V. Brusasco. 1998. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 157:4-9.
19. 19. Vrugt, B., R. Djukanović, A. Bron, and R. Aalbers. 1996. New insights into the pathogenesis of severe corticosteroid-dependent asthma. J. Allergy Clin. Immunol. 98(Suppl.):22-26.
20. 20. Leung, Y. M., R. J. Martin, S. J. Szefler, E. R. Sher, S. Ying, A. B. Kay, and Q. Hamid. 1995. Dysregulation of interleukin 4, interleukin 5, and interferon-γ gene expression in steroid-resistant asthma. J. Exp. Med. 181:33-40.
21. 21. Wenzel, E., S. J. Szefler, D. Y. M. Leung, S. I. Sloan, M. D. Rex, and R. J. Martin. 1997. Bronchoscopic evaluation of severe asthma. Am. J. Respir. Crit. Care Med. 156:737-743.
22. 1, mRNA expression and airways fibrosis in bronchial asthma, Am. J. Respir. Cell Mol. Biol. 17:326-333.
23. 23. Ronchi, M. C., C. Piragino, E. Rosi, L. Stendardi, A. Tanini, G. Galli, R. Duranti, and G. Scano. 1997. Do sputum eosinophils and ECP relate to the severity of asthma. Eur. Respir. J. 10:1809-1813.
24. 24. Poulter, L. W., A. Norris, C. Power, A. Condez, B. Schmekel, and C. Burke. 1992. T-cell dominated inflammatory reactions in the bronchi of asthmatics are not reflected in matched bronchoalveolar lavage specimens. Eur. Respir. J. 5:182-189.
25. 25. Grootendorst, D. C., J. K. Sont, L. N. A. Willems, J. C. Kluin Nelemans, J. H. J. M. VanKrieken, M. Veselic Charvat, and P. J. Sterk. 1997. Comparison of inflammatory cell counts in asthma: induced sputum vs. bronchoalveolar lavage and bronchial biopsies. Clin. Exp. Allergy 27:769-779.
26. 26. Djukanović, R., S. Homeyard, C. Gratziou, J. Madden, A. F. Walls, S. Montefort, D. Peroni, R. Polosa, S. T. Holgate, and P. H. Howarth. 1997. The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am. J. Respir. Crit. Care Med. 155: 826-832.
27. 27. Turner, M., P. Hussack, M. Sears, J. Dolovich, and F. E. Hargreave. 1995. Exacerbations of asthma without sputum eosinophilia. Thorax 50: 1057-1061.
28. 28. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, and G. J. Gleich. 1993. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa. Am. Rev. Respir. Dis. 148:713-719.
29. 29. Wardlaw, A., G. Walsh, and F. Symon. 1994. Mechanisms of eosinophil and basophil migration. Allergy 49:797-807.
30. 30. Pin, I., P. Gibson, R. Kolendowicz, A. Girgis-Gabardo, J. Denburg, F. Hargreave, and J. Dolovich. 1992. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 47:25-29.
31. 31. Ulrich, C. S., and J. Frederiksen. 1995. Mortality and markers of risk of asthma death among 1,075 out-patients with asthma. Chest 108:10-15.
32. 32. Azzawi, M., P. W. Johnston, S. Majumdar, A. B. Kay, and P. K. Jeffery. 1992. T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 145:1477-1482.
33. 33. Synek, M., R. Beasley, A. J. Frew, D. Goulding, L. Holloway, F. C. Lampe, W. R. Roche, and S. T. Holgate. 1996. Cellular infiltration of the airways in asthma of varying severity. Am. J. Respir. Crit. Care Med. 154:224-230.
34. 2-agonist, terbutaline on airway inflammation in newly diagnosed asthma: a randomized, double blind, parallel-group controlled trial. J. Allergy Clin. Immunol. 90:32-42.
35. 35. Robinson, D., Q. Hamid, S. Ying, A. M. Bentley, B. Assouffi, S. R. Durham, and A. B. Kay. 1993. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am. Rev. Respir. Dis. 148:401-406.
36. 36. Trigg, C., N. Manolitsas, J. Whang, M. Calderon, A. Mc Aulay, S. Jordan, M. Herdman, N. Jhally, J. Duddle, S. Hamilton, J. Devalia, and R. Davies. 1994. Placebo controlled immunopathologic study of four months of inhaled corticosteroid in asthma. Am. J. Respir. Crit. Care Med. 150:17-22.
37. 37. Hummel, S., L. Lehtonen, and Study Group. 1992. Comparison of oral steroid-sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 340:1483-1487.
38. 38. Booth, H., I. Richmond, C. Ward, P. Gardener, R. Harkawat, and H. Walters. 1995. Effect of high dose of inhaled fluticasone propionate on airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 152: 45-52.
39. 39. Corrigan, C. J., P. Brown, N. C. Barnes, S. J. Szefler, J.-J. Tsai, A. J. Frew, G. K. Crompton, and A. B. Kay. 1991. Glucocorticoid resistance in chronic asthma: glucocorticoid pharmacokinetics, glucocorticoid resistance characteristics and inhibition of peripheral blood T-cell proliferation by glucocorticoids in vitro. Am. Rev. Respir. Dis. 144: 1016-1025.
40. 40. Holt, P. G. 1985. Down-regulation of immune responses in the lower respiratory tract: role of alveolar macrophages. Clin. Exp. Immunol. 63: 261-270.